Novo Nordisk A/S - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US6701002056

SecurityNVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionAmerican Trust
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
American Trust closes position in NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On November 17, 2025 - American Trust filed a 13F-HR form disclosing ownership of 0 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (US:NVO) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on September 3, 2025 disclosing 7,721 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-17 2025-09-30 13F NOVO-NORDISK A Equities 670100205 0 -100.00 0
2025-09-03 2025-06-30 13F NOVO-NORDISK A Equities 670100205 7,721 2,356 43.91 533 43.01 0.0502
2025-05-16 2025-03-31 13F NOVO-NORDISK A Equities 670100205 5,365 -8,224 -60.52 373 -68.15 0.0918
2025-02-18 2024-12-31 13F NOVO-NORDISK A Equities 670100205 13,589 864 6.79 1,169 -22.90 0.0890
2024-11-29 2024-09-30 13F NOVO-NORDISK A Equities 670100205 12,725 7,402 139.06 1,515 99.60 0.1250
2024-09-12 2024-06-30 13F NOVO-NORDISK A Equities 670100205 5,323 -27 -0.50 760 10.64 0.0622
2024-06-11 2024-03-31 13F NOVO-NORDISK A Equities 670100205 5,350 -786 -12.81 687 8.20 0.0574
2024-02-21 2023-12-31 13F NOVO-NORDISK A Equities 670100205 6,136 122 2.03 635 16.12 0.0469
2023-11-15 2023-09-30 13F NOVO-NORDISK A Equities 670100205 6,014 2,517 71.98 547 -3.36 0.0424
2023-08-14 2023-06-30 13F NOVO-NORDISK A Equities 670100205 3,497 -100 -2.78 566 -1.22 0.0392
2023-05-22 2023-03-31 13F NOVO-NORDISK A Equities 670100205 3,597 -375 -9.44 572 6.52 0.0397
2023-02-16 2022-12-31 13F NOVO-NORDISK A Equities 670100205 3,972 -360 -8.31 538 24.31 0.0499
2022-12-02 2022-09-30 13F NOVO-NORDISK A Equities 670100205 4,332 -200 -4.41 432 -14.46 0.0364
2022-10-03 2022-06-30 13F NOVO-NORDISK A Equities 670100205 4,532 800 21.44 505 21.98 0.0405
2022-06-08 2022-03-31 13F NOVO-NORDISK A Equities 670100205 3,732 3,732 414 0.0278
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.